Global Custom Market Research Reports Provider Company

phone

Abcodia Ltd - Product Pipeline Analysis, 2018 Update

  • Published Date: 31 Oct 2018
  • Number of Pages: 36
  • Category: Company Profile
  • Country: United Kingdom
Summary

Abcodia Ltd (Abcodia) is a clinical stage company that offers commercial development of novel, scientifically validated tests for the early detection of cancer. The company offers Roca Test, a blood test for early ovarian cancer detection. It validates and discovers biomarkers for early diagnosis and screening of cancer. Abcodia develops products for the detection of breast cancer, colorectal cancer, pancreatic cancer, lung cancer, and liver disease. The company serves diagnostic, pharmaceutical and technology companies for validation and discovery of ethical biomarkers. It collaborates with global commercial, academic and charity partners. Abcodia is headquartered in Leeds, the UK.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Abcodia Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy
:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData


List of Tables 4
List of Figures 4
Abcodia Ltd Company Overview 5
Abcodia Ltd Company Snapshot 5
Abcodia Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Abcodia Ltd Pipeline Analysis Overview 7
Abcodia Ltd - Key Facts 7
Abcodia Ltd - Major Products and Services 8
Abcodia Ltd Pipeline Products by Development Stage 9
Abcodia Ltd Pipeline Products Overview 11
Biomarker Test - Liver Cancer 11
Biomarker Test - Liver Cancer Product Overview 11
Diagnostic Assay - Colorectal Cancer 12
Diagnostic Assay - Colorectal Cancer Product Overview 12
Diagnostic Assay - Haematological Cancer 13
Diagnostic Assay - Haematological Cancer Product Overview 13
Diagnostic Assay - Lung Cancer 14
Diagnostic Assay - Lung Cancer Product Overview 14
Diagnostic Assay - Oesophageal Cancer 15
Diagnostic Assay - Oesophageal Cancer Product Overview 15
Diagnostic Assay - Pancreatic Cancer 16
Diagnostic Assay - Pancreatic Cancer Product Overview 16
MCM Test - Lung Cancer 17
MCM Test - Lung Cancer Product Overview 17
Molecular Biomarker - Diabetes 18
Molecular Biomarker - Diabetes Product Overview 18
Molecular Biomarker - Osteoporosis 19
Molecular Biomarker - Osteoporosis Product Overview 19
Molecular Biomarker - Rheumatoid Arthritis 20
Molecular Biomarker - Rheumatoid Arthritis Product Overview 20
Abcodia Ltd - Key Competitors 21
Abcodia Ltd - Key Employees 22
Abcodia Ltd - Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Abcodia Ltd, Recent Developments 24
Sep 30, 2016: Abcodia Statement on the ROCA Test for Ovarian Cancer Screening in the UK 24
Jan 26, 2016: Abcodia Announces Expanded U.S. Availability of the ROCA Test for Early Ovarian Cancer Detection 24
Jan 11, 2016: Abcodia Restructures Leadership Team to Drive Commercialization of the ROCA Test 25
Dec 17, 2015: Data Published in The Lancet Suggest New Ovarian Cancer Screening Test Reduces Mortality 27
Dec 02, 2015: Abcodia Announces Initial U.S. Availability of the ROCA Test to Aid in the Early Detection of Ovarian Cancer 28
Nov 24, 2015: Abcodia Appoints Richard A. Sandberg to its Board of Directors 29
May 25, 2015: Abcodia appoints President of North America to Establish US Presence and Launch the Roca Test 29
May 18, 2015: Abcodia secures funding of 5.25 million ($8m) to launch the ROCA test for the early detection of ovarian cancer 30
May 12, 2015: Outstanding Results From Major Ovarian Cancer Screening Trial Shows the High Performance of ROCA, Paving the Way for Its Launch by Abcodia 31
May 05, 2015: New publication reaffirms high performance of ROCA in detecting ovarian cancer 31
Appendix 33
Methodology 33
About GlobalData 36
Contact Us 36
Disclaimer 36

List Of Tables


Abcodia Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Abcodia Ltd Pipeline Products by Equipment Type 6
Abcodia Ltd Pipeline Products by Indication 6
Abcodia Ltd, Key Facts 7
Abcodia Ltd, Major Products and Services 8
Abcodia Ltd Number of Pipeline Products by Development Stage 9
Abcodia Ltd Pipeline Products Summary by Development Stage 10
Biomarker Test - Liver Cancer - Product Status 11
Biomarker Test - Liver Cancer - Product Description 11
Diagnostic Assay - Colorectal Cancer - Product Status 12
Diagnostic Assay - Colorectal Cancer - Product Description 12
Diagnostic Assay - Haematological Cancer - Product Status 13
Diagnostic Assay - Haematological Cancer - Product Description 13
Diagnostic Assay - Lung Cancer - Product Status 14
Diagnostic Assay - Lung Cancer - Product Description 14
Diagnostic Assay - Oesophageal Cancer - Product Status 15
Diagnostic Assay - Oesophageal Cancer - Product Description 15
Diagnostic Assay - Pancreatic Cancer - Product Status 16
Diagnostic Assay - Pancreatic Cancer - Product Description 16
MCM Test - Lung Cancer - Product Status 17
MCM Test - Lung Cancer - Product Description 17
Molecular Biomarker - Diabetes - Product Status 18
Molecular Biomarker - Diabetes - Product Description 18
Molecular Biomarker - Osteoporosis - Product Status 19
Molecular Biomarker - Osteoporosis - Product Description 19
Molecular Biomarker - Rheumatoid Arthritis - Product Status 20
Molecular Biomarker - Rheumatoid Arthritis - Product Description 20
Abcodia Ltd, Key Employees 22
Glossary 35

List Of Figures


Abcodia Ltd Pipeline Products by Equipment Type 6
Abcodia Ltd Pipeline Products by Development Stage 9

Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson, is a medical device company that designs, manufactures and markets cardiac arrhythmias products. The companys products include ablation catheters,

View Report

Ondine Biomedical Inc (Ondine), formerly Ondine Biopharma Corp, a subsidiary of 0902337 B.C. Ltd, is a non-antibiotic anti-infective therapies developer for bacterial, viral, and fungal infections. The companys products include

View Report

Lucigen Corp (Lucigen), a subsidiary of LGC Ltd, is a medical device company that discovers, manufactures, and commercializes molecular biology product. The companys products comprise competent cells, nextgen seq, enzymes,

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports